Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Common Stock | Options Exercise | $0 | +2.68K | +10.51% | $0.00 | 28.1K | Feb 1, 2022 | Direct | |
transaction | LLY | Common Stock | Tax liability | -$293K | -1.19K | -4.24% | $245.39 | 26.9K | Feb 1, 2022 | Direct | |
holding | LLY | Common Stock | 128 | Feb 1, 2022 | by partner | F1 | |||||
holding | LLY | Common Stock | 2.68K | Feb 1, 2022 | 401(k) - by partner | F1 | |||||
holding | LLY | Common Stock | 514 | Feb 1, 2022 | 401(k) |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Restricted Stock Unit | Options Exercise | $0 | -2.68K | -100% | $0.00* | 0 | Feb 1, 2022 | Common Stock | 2.68K | Direct | F2 |
Id | Content |
---|---|
F1 | Reporting person disclaims beneficial ownership of these shares. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |